Neuropsychiatric Disorders in Hospitalized Patients Undergoing Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma

被引：0
|
作者：
Lawal, Odunayo [1 ]
Lupak, Oleksandra [2 ]
Udo, Itoro [3 ]
Emole, Josephine [4 ]
机构：
[1] Univ Arizona, Clin & Translat Sci Program, Tucson, AZ USA
[2] Med Univ South Carolina, Hematol Oncol, Charleston, SC 29425 USA
[3] Western Univ, Dept Psychiat, London, ON, Canada
[4] Henry Ford Hosp, Stem Cell Transplantat & Cellular Therapy, Detroit, MI 48202 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
CT; CAR-T therapy; neuropsychiatric disorders; multiple myeloma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT-423
引用
收藏
页码：S454 / S454
页数：1
相关论文
共 50 条
  • [41] Chimeric antigen receptor T cell therapies for multiple myeloma
    Chao Wu
    Lina Zhang
    Qierra R. Brockman
    Fenghuang Zhan
    Lijuan Chen
    Journal of Hematology & Oncology, 12
  • [42] Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma
    Fortuna, Gliceida Galarza
    Banerjee, Rahul
    Savid-Frontera, Constanza
    Song, Jinming
    Moran-Segura, Carlos M.
    Nguyen, Jonathan V.
    Lekakis, Lazaros
    Fernandez-Pol, Sebastian
    Samraj, Annie N.
    Naresh, Kikkeri N.
    Vazquez-Martinez, Mariola
    Baz, Rachid C.
    Spiegel, Jay Y.
    Mikkilineni, Lekha
    Gubatan, John M.
    Sidana, Surbhi
    Corraes, Andre de Menezes Silva
    Kalariya, Nilesh M.
    Patel, Krina K.
    Shim, Kevin G.
    Fonseca, Rafael
    Ferreri, Christopher
    Voorhees, Peter M.
    Richard, Shambavi
    Valdes, Cesar Rodriguez
    Wolf, Jeffrey L.
    Cowan, Andrew J.
    Sborov, Douglas W.
    Locke, Frederick L.
    Lin, Yi
    Wang, Yinghong
    Hansen, Doris K.
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [43] Chimeric antigen receptor T-cell therapy in patients with neurologic comorbidities
    Rubinstein, Jeremy D.
    Nelson, Adam S.
    Krupski, Christa
    O'Brien, William
    Taylor, J. Michael
    Badgett, Tom C.
    Huang, Michael
    Davies, Stella M.
    Phillips, Christine L.
    PEDIATRIC BLOOD & CANCER, 2020, 67 (04)
  • [44] Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Immunoglobulin D Multiple Myeloma
    Chen, Wei
    Wang, Ying
    Qi, Kunming
    Shi, Ming
    Cao, Jiang
    Bhansali, Rahul
    Wang, Xue
    Liu, Yang
    Li, Hujun
    Zhang, Huanxin
    Yan, Zhiling
    Sang, Wei
    Cheng, Hai
    Zhu, Feng
    Sun, Haiying
    Li, Depeng
    Jing, Guangjun
    Zheng, Junnian
    Li, Zhenyu
    Xu, Kailin
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (03): : 273.e1 - 273.e5
  • [45] Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment
    Sidana, Surbhi
    Peres, Lauren C.
    Hashmi, Hamza
    Hosoya, Hitomi
    Ferreri, Christopher
    Khouri, Jack
    Dima, Danai
    Atrash, Shebli
    Voorhees, Peter
    Simmons, Gary
    Sborov, Douglas W.
    Kalariya, Nilesh
    Hovanky, Vanna
    Bharadwaj, Sushma
    Miklos, David
    Wagner, Charlotte
    Kocoglu, Mehmet H.
    Kaur, Gurbakhash
    Davis, James A.
    Midha, Shonali
    Janakiram, Murali
    Freeman, Ciara
    Alsina, Melissa
    Locke, Frederick
    Gonzalez, Rebecca
    Lin, Yi
    Mcguirk, Joseph
    Afrough, Aimaz
    Shune, Leyla
    Patel, Krina K.
    Hansen, Doris K.
    HAEMATOLOGICA, 2024, 109 (03) : 777 - 786
  • [46] Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma
    Costa, Bruno Almeida
    Flynn, Jessica
    Nishimura, Noriko
    Devlin, Sean M.
    Farzana, Tasmin
    Rajeeve, Sridevi
    Chung, David J.
    Landau, Heather J.
    Lahoud, Oscar B.
    Scordo, Michael
    Shah, Gunjan L.
    Hassoun, Hani
    Maclachlan, Kylee
    Hultcrantz, Malin
    Korde, Neha
    Lesokhin, Alexander M.
    Shah, Urvi A.
    Tan, Carlyn R.
    Giralt, Sergio A.
    Usmani, Saad Z.
    Nath, Karthik
    Mailankody, Sham
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [47] Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment
    Hujun Li
    Lingling Yin
    Ying Wang
    Xiangmin Wang
    Ming Shi
    Jiang Cao
    Zhiling Yan
    Wei Sang
    Hai Cheng
    Feng Zhu
    Haiying Sun
    Depeng Li
    Guangjun Jing
    Junnian Zheng
    Zhenyu Li
    Kailin Xu
    Bone Marrow Transplantation, 2020, 55 : 2215 - 2218
  • [48] Recommendations on prevention of infections during chimeric antigen receptor T-cell and bispecific antibody therapy in multiple myeloma
    Mohan, Meera
    Chakraborty, Rajshekhar
    Bal, Susan
    Nellore, Anoma
    Baljevic, Muhamed
    D'Souza, Anita
    Pappas, Peter G.
    Berdeja, Jesus G.
    Callander, Natalie
    Costa, Luciano J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 203 (05) : 736 - 746
  • [49] Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: A Real-World Experience
    Lal, Bhavesh Mohan
    Pandey, Toshali
    Alzubi, Marah
    Alrawabdeh, Jawad
    Shaughnessy Jr, John D.
    Zhan, Fenghuang
    Siegel, Eric
    Schinke, Carolina
    Thanendrarajan, Sharmilan
    Zangari, Maurizio
    van Rhee, Frits
    Al Hadidi, Samer
    BLOOD, 2024, 144 : 2405 - 2406
  • [50] Cardiovascular Complications and Their Association With Short- and Long-Term Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy
    Ben Zadok, Osnat Itzhaki
    Simitsis, Panagiotis
    Jacobson, Caron
    Nadeem, Omar
    Frigault, Matthew J.
    Raje, Noopur
    Duffy, Caitlyn
    Costello, Patrick
    Dela Cruz, Jamie
    Looka, Andrew
    Nohria, Anju
    CIRCULATION, 2024, 150 (22) : 1815 - 1817
12345